Heyholder
‹ Activism FilingsMajor

AHN-GOOK PHARMACEUTICAL Co., Ltd. Q3 operating profit KRW 10.0 billion, up 104.1% from a year earlier

AHN-GOOK PHARMACEUTICAL Co., Ltd.· Periodic Report

AI summary · Not investment advice

Anguk Pharmaceutical sold KRW 97.2 billion in Q3 and earned KRW 10.0 billion from its main business, up 104.1% from a year earlier and 15.3% from the prior quarter.

Operating profit · 3 months

KRW 10.0 billion

Key facts

Revenue (3 months)
KRW 97.2 billion
Net income (3 months)
KRW 5.8 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 77.7 billion
Revenue (year to date)
KRW 288.0 billion
Operating profit (prior-year 3 months)
KRW 4.9 billion
Operating profit (year to date)
KRW 34.6 billion
Net income (prior-year 3 months)
KRW 3.4 billion
Net income (year to date)
KRW 26.8 billion

Commentary

AI commentary · Not investment advice

What happened

Anguk Pharmaceutical reported its consolidated results for the third quarter of 2026.

In the company's terms

Revenue for the 3 months was KRW 97.2 billion. That is 25.1% higher than the same 3 months a year earlier, and 5.8% higher than the previous quarter.

What changes for shareholders

Operating profit (profit from the core business) for the 3 months was KRW 9.97 billion. That is 104.1% higher than a year earlier, and 15.3% higher than the previous quarter.

Net income (final profit after taxes and all other costs) for the 3 months was KRW 5.85 billion. That is 74.1% higher than a year earlier, and 31.8% lower than the previous quarter.

For the year to date (Jan 1 to Sep 30), revenue was KRW 288.0 billion. Operating profit was KRW 34.63 billion, and net income was KRW 26.82 billion.

Comments

No comments yet

Comments from shareholders will appear here.